NCT05839665

Brief Summary

The goal of this randomised cross-over study is to compare pre-oxygenation using a standard nasal cannula to pre-oxygenation using humidified high-flow nasal oxygen and a tight-fitting facemask in adult volunteers with a BMI below 30 not suffering from pulmonary or cardiac comorbidity. The main question it aims to answer is: \- Are there any differences in the effectiveness of pre-oxygenation using a standard nasal cannula compared to using a traditional facemask and pre-oxygenation using humidified high-flow nasal oxygen? Participants will be pre-oxygenated with 100% oxygen during four minutes intervals. All participants will be pre-oxygenated with various flow rates using a standard nasal cannula, a facemask and humidified high-flow nasal oxygen. End-tidal oxygen concentrations will be measured continuously in order to evaluate the effectiveness of pre-oxygenation. Each volunteer will be pre-oxygenated repeatedly, with different flow rates, with all three methods of pre-oxygenation and act as its own control. During facemask pre-oxygenation volunteers will be pre-oxygenated using both tidal volume breathing for four minutes and with eight vital capacity breaths. During pre-oxygenation using the standard nasal cannula flow rates will vary between 15 and 50 l/min. Pre-oxygenation using humidified high-flow nasal oxygen will be performed with flow rates varying between 30 and 50 l/min. Series will be conducted with volunteers breathing with both opened and closed mouth as well as with four minutes of tidal volume breathing and eight vital capacity breaths. All volunteers will start with facemask pre-oxygenation. They will thereafter be randomised to pre-oxygenation with either a standard nasal cannula or humidified high-flow nasal oxygen. Lastly, they will be pre-oxygenated with the remaining method according to the randomisation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 20, 2023

Completed
12 days until next milestone

Study Start

First participant enrolled

May 2, 2023

Completed
1 day until next milestone

First Posted

Study publicly available on registry

May 3, 2023

Completed
28 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2023

Completed
Last Updated

August 8, 2023

Status Verified

August 1, 2023

Enrollment Period

29 days

First QC Date

April 20, 2023

Last Update Submit

August 7, 2023

Conditions

Keywords

PreoxygenationOxygenationHigh-flow nasal oxygenLow-flow nasal oxygen

Outcome Measures

Primary Outcomes (1)

  • Comparison of the effectiveness of pre-oxygenation

    Compare end-tidal oxygen levels after three minutes of pre-oxygenation using a standard facemask, high-flow nasal oxygen and a standard nasal cannula.

    After 3 minutes of preoxygenation

Secondary Outcomes (7)

  • Duration of pre-oxygenation until end-tidal oxygen levels above 80%

    After 3 minutes of preoxygenation

  • Duration of pre-oxygenation until end-tidal oxygen levels above 85%

    After 3 minutes of preoxygenation

  • Continuous comparison of end-tidal oxygen levels

    After 3 minutes of preoxygenation

  • Pre-oxygenation with open and closed mouth

    After 3 minutes of preoxygenation

  • Vital capacity breathing vs tidal volume breathing

    After 3 minutes of preoxygenation

  • +2 more secondary outcomes

Other Outcomes (1)

  • Safety outcome

    After 3 minutes of preoxygenation

Study Arms (3)

Humidified high-flow oxygen

ACTIVE COMPARATOR

Humidified high-flow nasal oxygen delivered via the Optiflow device. Repeated series with 100% oxygen with flows varying between 30 to 50 l/min. Volunteers will also be pre-oxygenated with both opened and closed mouth.

Device: Humidified high-flow nasal oxygen

Standard nasal cannula

EXPERIMENTAL

Standard nasal cannula connected to an oxygen rotameter Repeated series with 100% oxygen with flows varying between 15 to 50 l/min. Volunteers will also be pre-oxygenated with both opened and closed mouth.

Device: Standard nasal cannula

Facemask

ACTIVE COMPARATOR

Tight-fitting facemask. Two series will be done where pre-oxygenation will be performed with four minutes of tidal volume breathing and eight vital capacity breaths. This arm is not randomised. All study subjects will start with facemask pre-oxygenation and are thereafter randomised to standard nasal cannula or humidified high-flow nasal cannula.

Device: Facemask

Interventions

Humidified high-flow oxygen delivered via the Optiflow device

Humidified high-flow oxygen

Oxygen delivered with high flows via a standard nasal cannula

Standard nasal cannula
FacemaskDEVICE

Oxygen delivered with facemask

Facemask

Eligibility Criteria

Age25 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Ability to understand and sign informed consent
  • Age 25-65 years
  • Body mass index \<30

You may not qualify if:

  • Heart disease
  • Respiratory disease
  • Pregnancy
  • Smoker

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Perioperative Medicine and Intensive Care Medicine

Stockholm, SE-17176, Sweden

Location

Karolinska University Hospital, Solna

Stockholm, Sweden

Location

Related Publications (1)

  • Sjoblom A, Hedberg M, Forsberg IM, Hoffman F, Jonsson Fagerlund M. Comparison of preoxygenation using a tight facemask, humidified high-flow nasal oxygen and a standard nasal cannula - a volunteer, randomised, crossover study. Eur J Anaesthesiol. 2024 Jun 1;41(6):430-437. doi: 10.1097/EJA.0000000000001989. Epub 2024 Apr 16.

Study Officials

  • Malin Jonsson Fagerlund

    Karolinska University Hospital and Karolinska Institutet

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: All volunteers will start with pre-oxygenation using a traditional facemask (vital breathing for four minutes vital and eight vital capacity breaths). They will thereafter be randomised to continue with either pre-oxygenation using a standard nasal cannula or humidified high-flow nasal oxygen.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

April 20, 2023

First Posted

May 3, 2023

Study Start

May 2, 2023

Primary Completion

May 31, 2023

Study Completion

May 31, 2023

Last Updated

August 8, 2023

Record last verified: 2023-08

Data Sharing

IPD Sharing
Will not share

Locations